Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

Description

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Hubertus Jersmann

Prof Hubertus Jersmann

Spirometry for COPD - GP Guide

Dr Marita Long & Dr Talat Uppal

Dr Marita Long & Dr Talat Uppal

Q&A on Heavy Menstrual Bleeding Management

Prof Tony Attwood

Prof Tony Attwood

Women and Autism

Dr Robert Hungerford

Dr Robert Hungerford

Cardiovascular Risk Assessment in Lipid Management

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Andrew Scroop

expert

Dr Andrew Scroop

Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre

Date published: 24 January 2025